Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Neos Therapeutics, Inc. (NEOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/19/2021 4 Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 83,015 shares @ $0
Disposed/sold 150,000 options to buy @ $3.14, valued at $471k
Disposed/sold 115,000 options to buy @ $1.49, valued at $171.4k
03/19/2021 4 Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 23,453 shares @ $0
Disposed/sold 12,500 options to buy @ $2.03, valued at $25.4k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 270,171 shares @ $0
Disposed/sold 600,000 options to buy @ $6.2, valued at $3.7M
Disposed/sold 392,688 options to buy @ $2.31, valued at $907.1k
Disposed/sold 395,000 options to buy @ $1.49, valued at $588.6k
Disposed/sold 100,000 options to buy @ $5.55, valued at $555k
Disposed/sold 65,447 options to buy @ $2.31, valued at $151.2k
03/19/2021 4 Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 23,453 shares @ $0
Disposed/sold 12,500 options to buy @ $19.82, valued at $247.8k
Disposed/sold 14,777 options to buy @ $9.63, valued at $142.3k
Disposed/sold 18,322 options to buy @ $7.65, valued at $140.2k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 23,453 shares @ $0
Disposed/sold 12,500 options to buy @ $10.73, valued at $134.1k
Disposed/sold 14,777 options to buy @ $9.63, valued at $142.3k
Disposed/sold 18,322 options to buy @ $7.65, valued at $140.2k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 24,953 shares @ $0
Disposed/sold 12,500 options to buy @ $15, valued at $187.5k
Disposed/sold 14,777 options to buy @ $9.63, valued at $142.3k
Disposed/sold 18,322 options to buy @ $7.65, valued at $140.2k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 23,453 shares @ $0
Disposed/sold 12,500 options to buy @ $8.4, valued at $105k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 79,130 shares @ $0
Disposed/sold 10,416 options to buy @ $9.32, valued at $97.1k
Disposed/sold 12,500 options to buy @ $15, valued at $187.5k
Disposed/sold 14,777 options to buy @ $9.63, valued at $142.3k
Disposed/sold 18,322 options to buy @ $7.65, valued at $140.2k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 446,819 shares @ $0
Disposed/sold 12,500 options to buy @ $15, valued at $187.5k
Disposed/sold 14,777 options to buy @ $9.63, valued at $142.3k
Disposed/sold 18,322 options to buy @ $7.65, valued at $140.2k
Disposed/sold 22,756 options to buy @ $6.05, valued at $137.7k
Disposed/sold 46,907 options to buy @ $1.44, valued at $67.5k
03/19/2021 4 Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Disposed/sold 126,245 shares @ $0
Disposed/sold 86,167 options to buy @ $2.91, valued at $250.7k
Disposed/sold 12,500 options to buy @ $9.32, valued at $116.5k
Disposed/sold 60,230 options to buy @ $25.5, valued at $1.5M
Disposed/sold 50,000 options to buy @ $10.74, valued at $537k
Disposed/sold 45,000 options to buy @ $7, valued at $315k
Disposed/sold 56,250 options to buy @ $8.3, valued at $466.9k
Disposed/sold 230,276 options to buy @ $2.31, valued at $531.9k
Disposed/sold 115,000 options to buy @ $1.49, valued at $171.4k
03/16/2021 4 McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Paid exercise price by delivering 44,329 shares @ $0.844, valued at $37.4k
03/16/2021 4 Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Paid exercise price by delivering 16,985 shares @ $0.844, valued at $14.3k
03/16/2021 4 Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,390 shares @ $0.883, valued at $1.2k
Paid exercise price by delivering 14,825 shares @ $0.844, valued at $12.5k
06/11/2020 4 Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
06/11/2020 4 Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 23,453 shares @ $0
03/16/2020 4 McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $5.55, valued at $555k
Granted 65,447 options to buy @ $2.31, valued at $151.2k
03/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2020 4 McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 290,000 shares @ $0
Granted 395,000 options to buy @ $1.49, valued at $588.6k
03/04/2020 4 Eisenstadt Richard I (CFO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0
Granted 115,000 options to buy @ $1.49, valued at $171.4k
06/17/2019 4 Szyper Linda M (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 ROBITAILLE GREGORY J (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 Robinson James A. Jr. (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 HELLER ALAN L (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 Hecht Beth (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 4 Fong Bryant (Director) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 46,907 options to buy @ $1.44, valued at $67.5k
06/17/2019 3/A Szyper Linda M (Director) has filed a Form 3/A on Neos Therapeutics, Inc.
03/22/2019 4/A McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 392,688 options to buy @ $2.31, valued at $907.1k
03/22/2019 4 Limongelli John M (SVP & General Counsel) has filed a Form 4 on Neos Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $3.14, valued at $471k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy